New CFO appointed at Intercytex
This article was originally published in Scrip
Executive Summary
Intercytex Group (UK), a developer of regenerative medicine products to restore skin and hair, has appointed Max Herrmann chief financial officer, effective September 19th. Mr Herrmann joins from Fusion IP, a university IP commercialisation company, where he has held an independent consulting role for the past 12 months.